Patients with codeleted mutated tumors ( 14.7 v 6.8 years ; HR , 0.49 ; 95 % CI , 0.28 to 0.85 ; P = .01 ) and noncodeleted mutated tumors ( 5.5 v 3.3 years ; HR , 0.56 ; 95 % CI , 0.32 to 0.99 ; P < .05 ) lived longer after CRT than RT. .